December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares (NQ:KNSA)

81.46 +2.02 (+2.54%)
Streaming Delayed Price Updated: 3:23 PM EDT, Jul 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares

< Previous 1 2 3 4 5 6 Next >
News headline image
3 Small-Cap Stocks That Are Worth the Gamble ↗
Although these small-cap stock picks may not be household names, they command significant upside potential for daring speculators. 
Via InvestorPlace
News headline image
Abcam Stock Earns Relative Strength Rating Upgrade ↗
A Relative Strength Rating upgrade for Abcam ADR shows improving technical performance. 
Via Investor's Business Daily
News headline image
FibroGen Stock Joins Rank Of Stocks With RS Ratings Over 90 ↗
On Tuesday, FibroGen stock saw a positive improvement to its Relative Strength Rating, rising to 94 from 90 a day earlier. 
Via Investor's Business Daily
News headline image
Overview Of Value Stocks In The Healthcare Sector ↗
 
Via Benzinga
News headline image
A Look Into Healthcare Sector Value Stocks ↗
 
Via Benzinga
News headline image
7 Thrilling Biotech Stocks for Aggressive Investors to Buy ↗
Amid the noise of the global markets recently, these speculative biotech stocks to buy might trade with a mind of their own. 
Via InvestorPlace
5 Value Stocks In The Healthcare Sector ↗
 
Via Benzinga
News headline image
Kiniksa Inks Global License Agreement With Roche For Vixarelimab ↗
 
Via Benzinga
News headline image
Recap: Kiniksa Pharmaceuticals Q1 Earnings ↗
Kiniksa Pharmaceuticals (NASDAQ:KNSA) reported its Q1 earnings results on Tuesday, May 3, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
7 Small-Cap Stocks to Buy for Explosive Growth Potential ↗
Although small-cap stocks to buy presents higher risks than the large caps, the segment also enjoys critical advantages. 
Via InvestorPlace
News headline image
7 Dirt-Cheap Stocks Sitting in the Sweet Spot ↗
These cheap stocks don’t just attract on the ticker tape but rather feature compelling fundamentals and analysts’ upside projections. 
Via InvestorPlace
News headline image
The Top 7 Growth Stocks in Biotech ↗
The biotech sector always houses a great selection of growth stocks that can grow rapidly and reward investors over the long-term. 
Via InvestorPlace
News headline image
Gartner, Sony, Uber And Other Big Gainers From Tuesday ↗
U.S. stocks closed lower on Tuesday, with the Nasdaq Composite dropping around 100 points. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga
News headline image
Earnings Scheduled For February 22, 2022 ↗
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report quarterly earnings at $0.13 per share on revenue of $439.63 million. • Sohu... 
Via Benzinga
News headline image
Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday ↗
Gainers 
Via Benzinga
News headline image
Why Abiomed Shares Are Trading Higher By Over 50%? Here Are 60 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Safe-T Group Ltd (NASDAQ: SFET) shares surged 63.7% to $0.4910 as the company said its privacy application reached over 5,000,000 downloads. 
Via Benzinga
News headline image
Recap: Kiniksa Pharmaceuticals Q3 Earnings ↗
Kiniksa Pharmaceuticals (NASDAQ:KNSA) reported its Q3 earnings results on Tuesday, November 1, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Earnings Kiniksa... 
Via Benzinga
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
News headline image
Kiniksa Pharmaceuticals: Q2 Earnings Insights ↗
  Kiniksa Pharmaceuticals (NASDAQ:KNSA) reported its Q2 earnings results on Wednesday, August 3, 2022. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
On Wednesday, 73 stocks hit new 52-week lows. 
Via Benzinga
News headline image
Week In Review: Huadong Pharma Enters $662 Million Deal For Two Kiniksa Anti-Inflammatory Drugs ↗
Huadong Pharma announced a $662 million agreement to develop two Kiniksa Pharma anti-inflammatory drug candidates in southeast Asia (ex-Japan). Huadong will pay $22 million and be responsible for up to... 
Via Talk Markets
News headline image
Kiniksa Pharma, Huadong Medicine Ink Licensing Pact For Arcalyst, Mavrilimumab ↗
Kiniksa Pharmaceuticals Ltd (NASDAQ: KNSA) and Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd., a subsidiary of Huadong Medicine Co., Ltd., have announced a strategic... 
Via Benzinga
News headline image
Kiniksa Pharmaceuticals: Q4 Earnings Insights ↗
Kiniksa Pharmaceuticals (NASDAQ:KNSA) reported its Q4 earnings results on Tuesday, February 22, 2022 at 08:00 AM. Here's what investors need to know about the... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Gainers Black Diamond Therapeutic (NASDAQ:BDTX) stock increased by 18.2% to $5.32 during Tuesday's pre-market session. The market value of their outstanding shares is... 
Via Benzinga
News headline image
10 Biggest Price Target Changes For Wednesday ↗
Tigress Financial lifted the price target on McDonald's Corporation (NYSE: 
Via Benzinga
News headline image
Why Kiniksa Pharmaceuticals Stock Is Falling Today ↗
Kiniksa Pharmaceuticals Ltd (NASDAQ: KNSA) is trading lower Tuesday morning after the company announced the Phase 3 trial of mavrilimumab in COVID-19-related ARDS did not... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Gainers BiondVax Pharmaceuticals (NASDAQ:BVXV) shares moved upwards by 41.2% to $3.29 during Tuesday's pre-market session. The company's market cap stands at $47.1... 
Via Benzinga
News headline image
71 Biggest Movers From Yesterday ↗
Gainers Avis Budget Group, Inc. (NASDAQ: CAR) shares climbed 108.3% to close at $357.17 on Tuesday after the company reported better-than-expected Q3 adjusted EPS and sales... 
Via Benzinga
News headline image
Mid-Afternoon Market Update: Dow Rises Around 150 Points; Semler Scientific Shares Slide ↗
Toward the end of trading Tuesday, the Dow traded up 0.42% to 36,063.98 while the NASDAQ rose 0.03% to 15,600.42. The S&P also rose, gaining 0.28% to 4,626.45. The U.S. has... 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
Gainers Kiniksa Pharmaceuticals (NASDAQ:KNSA) stock increased by 16.73% to $14.86 during Tuesday's regular session. The current volume of 1.0 million shares is 269.7%... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.